, Tracking Stock Market Picks
Enter Symbol:
Pharmacyclics, Inc. (PCYC) [hlAlert]

up 6,225.66 %

Pharmacyclics, Inc. (PCYC) rated Buy by Merriman

Posted on: Friday,  Jan 29, 2010  8:25 AM ET by Merriman

Merriman rated Buy Pharmacyclics, Inc. (NASDAQ: PCYC) on 01/29/2010, when the stock price was $4.13. Since
then, Pharmacyclics, Inc. has gained 6225.67% as of 05/22/2015's recent price of $261.25.
If you would have followed this Merriman's recommendation on PCYC, you would have gained 6225.66% of your investment in 1939 days.

Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2010 8:25 AM Buy
as of 12/31/2010
1 Week down  -18.38 %
1 Month down  -5.50 %
3 Months down  -36.26 %
1 YTD up  24.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy